Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, PDT

New Toolkit to Support Medical Students and Programs in the Transition to Residency during the COVID-19 Pandemic


CHICAGO, May 6, 2021 /PRNewswire/ -- In an effort to help medical students entering residency programs during the COVID-19 pandemic, several organizations across the medical continuum came together to create a toolkit with guidelines, resources, and activities to ease the transition. The Accreditation Council for Graduate Medical Education (ACGME), American Association of Colleges of Osteopathic Medicine, Association of American Medical Colleges, and Educational Commission for Foreign Medical Graduates | Foundation for Advancement of International Medical Education and Research designed the toolkit to aid programs preparing for incoming residents, as well as help students entering residency after a challenging and potentially disrupted final year of medical school.

This year more than ever, it is essential to ensure that the incoming intern class has a robust educational experience.

Created by a work group that included medical students and residents, the toolkit is divided into three main sections: questions to review, a matrix of possible activities, and a comprehensive list of additional resources. The toolkit's recommendations should not be viewed as requirements.

"This year more than ever, it is essential to ensure that the incoming intern class has a robust educational experience, especially considering some experiences in medical school may have been interrupted or cancelled entirely. To that end, we have prepared these resources to help incoming interns and program directors optimize the graduate medical education curriculum for incoming interns," said two medical students and a resident who worked on the toolkit.

Section I lists key topics and questions for program leaders to answer to better meet the needs of incoming residents. Issues include COVID-19 safety, personal protective equipment (PPE), vaccines, patient safety, well-being, and transition logistics. Section II features resources and recommendations for program curricula, assessing and advising residents, and guidance to eliminate bias and inequity. The final section has a collection of resources from partnering organizations on a variety of topics.

Access the toolkit on the ACGME website.

The ACGME is a private, non-profit, professional organization responsible for the accreditation of over 12,000 residency and fellowship programs and the approximately 865 institutions that sponsor these programs in the United States. Residency and fellowship programs educate approximately 145,000 resident and fellow physicians in 182 specialties and subspecialties. The ACGME's mission is to improve health care and population health by assessing and enhancing the quality of resident and fellow physicians' education through advancements in accreditation and education.

SOURCE Accreditation Council for Graduate Medical Education


These press releases may also interest you

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: